本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Soleno Therapeutics

75.23
+0.21000.28%
盘后77.732.50+3.32%19:35 EDT
成交量:42.41万
成交额:3,193.15万
市值:37.55亿
市盈率:-17.19
高:76.16
开:75.95
低:74.74
收:75.02
数据加载中...
2023/08/16

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/16

重要事件披露

Form 8-K - Current report
2023/08/09

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/08

重要事件披露

Form 8-K - Current report
2023/07/31

SEC问询函

Form CORRESP - Correspondence
2023/07/28

[修订]招股说明书

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/07/21

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/07/11

重要事件披露

Form 8-K - Current report
2023/06/07

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/06/01

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/30

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/27

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/26

重要事件披露

Form 8-K - Current report
2023/05/25

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/19

超过5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/05/15

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/05/10

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]